Peptic ulcer disease (PUD) remains a prevalent gastrointestinal disorder that poses significant morbidity and mortality worldwide. The evolution of its management has been dramatic over the past few decades, thanks to the advent of novel diagnostic tools and therapeutic strategies.
Endoscopy and biopsy, the gold-standard diagnostic tools for PUD, have seen significant advancements. Enhanced imaging techniques like narrow band imaging and high-definition endoscopy have improved the detection and characterization of ulcers. Moreover, non-invasive tests like urea breath test and stool antigen test for Helicobacter pylori, the most common cause of PUD, have simplified the diagnostic process.
Proton pump inhibitors (PPIs) have long been the cornerstone of PUD treatment. Recent developments have led to the introduction of Vonoprazan, a potassium-competitive acid blocker, providing a more potent and long-lasting acid suppression. The management of H. pylori has also evolved with quadruple therapy replacing the traditional triple therapy, increasing the eradication rates.
For PUD complications such as bleeding, endoscopic therapy has emerged as a first-line treatment. Techniques like endoscopic clipping, thermal coagulation, and injection therapy have improved the control of ulcer bleeding. Moreover, endoscopic submucosal dissection (ESD) has been a game-changer for early gastric cancer associated with PUD.
The landscape of PUD management has significantly changed with advancements in diagnostic and therapeutic modalities. These improvements have led to better patient outcomes, including higher ulcer healing rates, increased H. pylori eradication, and improved control of complications. As healthcare professionals, it is crucial to stay updated with these advancements to provide optimal care to our patients.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
Black Canadians Face Multiple Barriers to Blood Donation
3.
Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Clinical Frameworks in Hematology for Better Care
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation